| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12072-015-9671-8 |
| P698 | PubMed publication ID | 26449425 |
| P50 | author | Qing-Lei Zeng | Q83317040 |
| P2093 | author name string | Zheng Zhang | |
| Jin Han | |||
| Yi Dong | |||
| Pu Wang | |||
| Da-Wei Chen | |||
| Fu-Sheng Wang | |||
| Yu Gan | |||
| Li-Min Wang | |||
| Hong-Fei Zhang | |||
| Fu-Chuan Wang | |||
| Shi-Shu Zhu | |||
| Zhi-Qiang Xu | |||
| Li-Li Cao | |||
| Jian-Guo Yan | |||
| Xue-Xiu Zhang | |||
| P2860 | cites work | Therapy of hepatitis C--back to the future. | Q43034466 |
| Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. | Q43041928 | ||
| The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period | Q45417690 | ||
| General Epidemiological Parameters of Viral Hepatitis A, B, C, and E in Six Regions of China: A Cross-Sectional Study in 2007 | Q27490512 | ||
| Clinical practice. Chronic hepatitis C infection | Q28241445 | ||
| Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 | ||
| Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 | ||
| High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin | Q33388409 | ||
| EASL Clinical Practice Guidelines: management of hepatitis C virus infection | Q34168383 | ||
| Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. | Q34320498 | ||
| The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C. | Q34588247 | ||
| Classification of chronic viral hepatitis: a need for reassessment | Q37032966 | ||
| Diagnosis and management of hepatitis C virus-infected children | Q37945518 | ||
| The natural history of hepatitis C virus infection acquired during childhood | Q37958084 | ||
| Management of chronic hepatitis C infection in children | Q37966934 | ||
| NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents | Q38001268 | ||
| Treating hepatitis C in lower-income countries | Q42225542 | ||
| Curing chronic hepatitis C--the arc of a medical triumph | Q42225548 | ||
| Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease | Q42978075 | ||
| Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening | Q42995334 | ||
| Chronic hepatitis C in childhood: an 18-year experience. | Q42995976 | ||
| Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics | Q42996149 | ||
| Treating hepatitis C: are children the same as adults? | Q43032225 | ||
| P433 | issue | 4 | |
| P921 | main subject | ribavirin | Q421862 |
| virology | Q7215 | ||
| P304 | page(s) | 578-585 | |
| P577 | publication date | 2015-10-08 | |
| P1433 | published in | Hepatology international | Q26842730 |
| P1476 | title | Interferon-α plus ribavirin yields 98 % sustained virologic response in children aged 1-5 years with iatrogenic chronic hepatitis C | |
| P478 | volume | 9 |
| Q54277218 | Hepatitis C virus infection in children and adolescents. | cites work | P2860 |
Search more.